Xintela AB (publ) 1XT.F Stock
Xintela AB (publ) Price Chart
Xintela AB (publ) 1XT.F Financial and Trading Overview
| Xintela AB (publ) stock price | 0.01 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.01 EUR |
| Bid | 0.02 EUR x N/A |
| Ask | 0.03 EUR x N/A |
| Day's Range | 0.01 - 0.01 EUR |
| 52 Week Range | 0.0004 - 0.07 EUR |
| Volume | 4.13K EUR |
| Avg. Volume | 87 EUR |
| Market Cap | 5.45M EUR |
| Beta (5Y Monthly) | 1.504597 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
1XT.F Valuation Measures
| Enterprise Value | 4.8M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Xintela AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.504597 |
| 52-Week Change | -41.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 EUR |
| 52 Week Low | 0.0004 EUR |
| 50-Day Moving Average | 0.01 EUR |
| 200-Day Moving Average | 0.02 EUR |
1XT.F Share Statistics
| Avg. Volume (3 month) | 87 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 307.57M |
| Float | 276.56M |
| Short Ratio | N/A |
| % Held by Insiders | 58.83% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -259.20% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.46 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Xintela AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 81 |
| Phone | 46 4 62 75 65 00 |
| Website | https://www.xintela.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 25 |
Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company develops products based on XINMARK, a patented technology platform; XSTEM, a stem cell platform for the treatment of knee osteoarthritis and difficult-to-heal leg ulcers; EQSTEM for the joint disease treatment in horses; CANISTEM for stem cell treatment in dogs; and XACT, an analytical test for cartilage cells. It is also involved in the development of TARG9 and TARG10, therapeutic antibodies targeting integrin aiopi for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. The company's trademarks also include XINTELA and TARGINTA. Xintela AB (publ) was founded in 2009 and is based in Lund, Sweden.
Q&A For Xintela AB (publ) Stock
What is a current 1XT.F stock price?
Xintela AB (publ) 1XT.F stock price today per share is 0.01 EUR.
How to purchase Xintela AB (publ) stock?
You can buy 1XT.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xintela AB (publ)?
The stock symbol or ticker of Xintela AB (publ) is 1XT.F.
Which industry does the Xintela AB (publ) company belong to?
The Xintela AB (publ) industry is Biotechnology.
How many shares does Xintela AB (publ) have in circulation?
The max supply of Xintela AB (publ) shares is 1.04B.
What is Xintela AB (publ) Price to Earnings Ratio (PE Ratio)?
Xintela AB (publ) PE Ratio is now.
What was Xintela AB (publ) earnings per share over the trailing 12 months (TTM)?
Xintela AB (publ) EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Xintela AB (publ) company belong to?
The Xintela AB (publ) sector is Healthcare.